Related Experiment Video
Updated: Jan 7, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Hypertrophic Cardiomyopathy Phenocopies: Classification, Key Features, and Differential Diagnosis
Lucio Teresi1,2,3, Giancarlo Trimarchi4, Roberto Licordari1
1Department of Clinical and Experimental Medicine, University of Messina, 98100 Messina, Italy.
Insights
Hypertrophic cardiomyopathy (HCM) phenocopies mimic HCM but have diverse causes. Accurate diagnosis is vital for targeted treatments and improved outcomes in these complex conditions.
Area of Science:
- Cardiology
- Genetics
- Internal Medicine
Background:
- Hypertrophic cardiomyopathy (HCM) is the most common cardiomyopathy.
- HCM phenocopies share features with HCM but have distinct etiologies (genetic, metabolic, infiltrative).
- Accurate diagnosis is crucial for effective management and treatment.
Purpose of the Study:
- To provide an overview of HCM phenocopies.
- To assist clinicians in the differential diagnosis of HCM phenocopies.
- To highlight the therapeutic implications of accurate diagnosis.
Main Methods:
- Review of classification based on pathophysiological mechanisms, clinical features, and genetics.
- Stepwise diagnostic approach integrating clinical assessment, laboratory tests, ECG, echocardiography, and cardiac magnetic resonance (CMR).
- Emphasis on genetic testing for mutation and inheritance pattern identification.
Main Results:
- Sarcomeric HCM accounts for up to 60% of cases.
- Non-sarcomeric phenocopies include amyloidosis, Fabry disease, glycogen storage disorders, RASopathies, and mitochondrial diseases.
- Clinical and imaging findings are key to distinguishing phenocopies from sarcomeric HCM.
Conclusions:
- Correct identification of HCM phenocopies is essential for guiding disease-specific therapies.
- Targeted treatments for conditions like amyloidosis and Fabry disease significantly improve prognosis.
- Accurate diagnosis of HCM phenocopies has direct and important therapeutic implications.
Abstract:
Among cardiomyopathies, the hypertrophic phenotype is the most common, and hypertrophic cardiomyopathy (HCM) phenocopies represent a heterogeneous group of conditions. They are defined by a left ventricular wall thickness ≥15 mm in the absence of other causes such as loading conditions, ischemia, or valvular disease. Although they mimic similar clinical and morphological features, their etiologies are distinct and include genetic, metabolic, and infiltrative mechanisms. Therefore, accurate classification and differential diagnosis are crucial for effective management and treatment. Sarcomeric HCM is the most frequent form, accounting for up to 60% of cases. However, numerous non-sarcomeric phenocopies exist, including amyloidosis, Fabry disease, glycogen storage disorders, RASopathies, and mitochondrial diseases. Clinical and imaging findings are essential to distinguish these entities from sarcomeric HCM. Electrocardiography, echocardiography, advanced modalities such as cardiac magnetic resonance (CMR), and specific laboratory tests all play a central role in guiding diagnosis. Genetic testing provides key insights into mutations and inheritance patterns, further supporting definitive diagnosis. Correct identification of an HCM phenocopy carries important therapeutic implications, as disease-specific treatments can significantly improve prognosis. For example, targeted therapies exist for amyloidosis, Fabry disease, and certain metabolic or mitochondrial disorders, underlining the clinical relevance of an accurate diagnosis. This review aims to provide an overview of HCM phenocopies and assist clinicians in diagnostic reasoning. The first part addresses classification according to pathophysiological mechanisms, clinical features, and genetic background. The second part focuses on the stepwise approach to differential diagnosis, integrating clinical assessment, laboratory evaluation, ECG, echocardiography, and CMR findings.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Pathophysiology of Heart Failure
Cardiomyopathy IV: Restrictive Cardiomyopathy

